LifeMD (LFMD) Capital Expenditures Growth (3y) (2023 - 2025)
LifeMD (LFMD) Capital Expenditures Growth (3y) (2023 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (3y) (Qtr) |
| 1 |
Veeva Systems |
32.63 Bn |
25.32 Bn |
662.02 Mn |
-16.04% |
| 2 |
Healthequity |
8.50 Bn |
8.24 Bn |
256.31 Mn |
411.55% |
| 3 |
10x Genomics |
5.97 Bn |
5.43 Bn |
106.18 Mn |
-70.42% |
| 4 |
Hinge Health |
5.82 Bn |
5.50 Bn |
154.23 Mn |
- |
| 5 |
MiniMed |
4.63 Bn |
4.33 Bn |
480.00 Mn |
- |
| 6 |
Waystar Holding |
4.62 Bn |
4.56 Bn |
216.84 Mn |
- |
| 7 |
Doximity |
3.99 Bn |
3.24 Bn |
125.97 Mn |
-63.51% |
| 8 |
Privia Health |
3.14 Bn |
2.72 Bn |
- |
-25.65% |
| 9 |
Omnicell |
1.92 Bn |
1.68 Bn |
140.36 Mn |
-43.93% |
| 10 |
LifeMD |
172.40 Mn |
135.28 Mn |
2.85 Mn |
-78.50% |
| Date | Value |
|---|
| Dec 31, 2025 |
-78.50% |
| Sep 30, 2025 |
5.64% |
| Jun 30, 2025 |
-181.31% |
| Mar 31, 2025 |
117.40% |
| Dec 31, 2024 |
350.73% |
| Sep 30, 2024 |
-54.24% |
| Jun 30, 2024 |
40.17% |
| Mar 31, 2024 |
245.48% |
| Dec 31, 2023 |
396.87% |
| Mar 31, 2023 |
196.23% |
